Abstract: GAL(1-15) and analogues thereof for use in the prevention and/or treatment of alcohol-related effects and disorders. The present invention relates to the use of galanin(1-15), which has the general formula Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala (GWTLNSAGYLLGPHA)(SEQ ID NO: 1), or an analogue thereof, or pharmaceutically acceptable salt, ester, tautomer, solvate, or hydrate thereof, or a pharmaceutical composition or kit comprising any of same, for use in the prevention and/or treatment of alcohol-related effects and disorders, especially the use thereof to reduce alcohol consumption.

Abstract: The invention provides pyridinylsulfonamide compounds, pharmaceutical compositions, their use for inhibiting mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), and their use in the treatment of a disease or condition, such as a proliferative disorder, inflammatory disorder, or autoimmune disorder.

Abstract: The invention provides pyrazolylsulfonamide compounds, pharmaceutical compositions, their use for inhibiting mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), and their use in the treatment of a disease or condition, such as a proliferative disorder, inflammatory disorder, or autoimmune disorder.

Abstract: The present disclosure provides compositions and methods for producing transgenic banana plants that exhibit increased resistance to Fusarium oxysporum f.sp. cubense Tropical Race 4 (TR4), and the banana plants and bananas so produced.

Abstract: There is provided a computer-implemented method for enabling an Application Function (AF) to request User Plane capabilities of a Mobile Network Operator (MNO). The method comprises requesting, by the AF from a Network Exposure Function (NEF), one or more UP capability groups for a first application identifier (App-ID) and/or one or more UP capabilities for the first App-ID, providing, from the NEF to a network entity, information associated with the one or more UP capability groups for the first App-ID and/or one or more UP capabilities for the first App-ID, storing, at the network entity, the one or more UP capability groups for the first App-ID and/or one or more UP capabilities for the first App-ID; and providing an indication from the NEF to the AF to indicate that the request has been accepted.

Abstract: This disclosure provides a machine learning technique to predict a protein characteristic. A first training set is created that includes, for multiple proteins, a target feature, protein sequences, and other information about the proteins. A first machine learning model is trained and then used to identify which of the features are relevant as determined by feature importance or causal relationships to the target feature. A second training set is created with only the relevant features. Embeddings generated from the protein sequences are also added to the second training set. The second training set is used to train a second machine learning model. The first and second machine learning models may be any type of regressors. Once trained, the second machine learning model is used to predict a value for the target feature for an uncharacterized protein. The model of this disclosure provides 91% accuracy in predicting an ideal digestibility score.

Abstract: A first aspect of the invention relates to a process for separating 1-methoxypropan-2-ol from an aqueous stream comprising 1-methoxypropan-2-ol and 2-methoxypropan-1-ol, wherein the process comprises providing a stream SO comprising 1-methoxypropan-2-ol, 2-methoxypropan-1-ol and water, and having a molar ratio of 1-methoxypropan-2-ol:2-methoxypropan-1-ol in the range of from 1:5 to 5:1; wherein the final stream S5 comprises ?95 weight-% 1-methoxypropan-2-ol based on the total weight of S5. In a second aspect, the invention relates to 1-methoxypropan-2-ol or a mixture of 1-methoxypropan-2-ol and 2-methoxypropan-1-ol obtained or obtainable from the process of the first aspect.

Abstract: A deep learning system is used to predict crop characteristics from inputs that include crop variety features, environmental features, and field management features. The deep learning system includes domain-specific modules for each category of features. Some of the domain-specific modules are implemented as convolutional neural networks (CNN) while others are implemented as fully-connected neural networks. Interactions between different domains are captured with cross attention between respective embeddings. Embeddings from the multiple domain-specific modules are concatenated to create a deep neural network (DNN). The prediction generated by the DNN is a characteristic of the crop such as yield, height, or disease resistance. The DNN can be used to select a crop variety for planting in a field. For a crop that is planted, the DNN may be used to select a field management technique.

Abstract: The present invention relates to a process for separating 1-methoxypropan-2-ol in a stream S3 from an aqueous stream comprising 1-methoxypropan-2-ol and 2-methoxypropan-1-ol, wherein the process comprises providing a stream S0 comprising 1-methoxypropan-2-ol, 2-methoxypro-pan-1-ol and water, and having a molar ratio of 1-methoxypropan-2-ol:2-methoxypropan-1-ol in the range of from 1:5 to 5:1. A further aspect of the invention also relates to 1-methoxypropan-2-ol obtained or obtainable from said process, as well as to a mixture of 1-methoxypropan-2-ol and 2-methoxypropan-1-ol, preferably obtained or obtainable from said process, which preferably comprises in the range of from 95 to 100 weight-% 1-methoxypropan-2-ol and ?0.5 weight-% of 2-methoxypropan-1-ol, each based on the total weight of the mixture.

Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. The present invention relates to methods for minimising the progression of cancer in a subject, the method comprising administering to the subject therapeutically effective amounts of chymotrypsinogen and trypsinogen, thereby minimising the progression of cancer in the subject. In particular, the methods provide a means for treating cancer by reducing the number of cancer stem cells in the subject.

Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. The present invention relates to methods for minimising the progression of cancer in a subject, the method comprising administering to the subject therapeutically effective amounts of chymotrypsinogen and trypsinogen, thereby minimising the progression of cancer in the subject. In particular, the methods provide a means for treating cancer by reducing the number of cancer stem cells in the subject.

Abstract: The present invention relates to compositions, methods, uses and kits for treating cancer. The present invention relates to methods for minimising the progression of cancer in a subject, the method comprising administering to the subject therapeutically effective amounts of chymotrypsinogen and trypsinogen, thereby minimising the progression of cancer in the subject. In particular, the methods provide a means for treating cancer by reducing the number of cancer stem cells in the subject.

Abstract: The present invention relates to a serum-free conditioned medium that solves the drawbacks mentioned in the prior art, as it does not require prior handling of the cells, and it furthermore allows starting from a large population with no additional cost. This medium favors in vitro proliferation and conservation of the pluripotency potential that allows maintaining a state that is undifferentiated with respect to the subpopulation of cancer stem cells (CSCs) and in turn does not allow survival of the differentiated cells.

Abstract: A system and method that facilitates the transformation of PTVs, when in the “OFF” mode, into aesthetically pleasing decorative furniture. The PTV preferably includes a primary and a secondary projection system. The secondary projection system preferably comprises a projection unit optically coupled to the screen of the PTV and an auxiliary image source coupled to the projection unit. Preferably, the program logic of the PTV directs the projection of an image from the secondary projection unit onto the screen when the PTV is in the “OFF” mode.